Clinical Trials in Chicago

Showing 10841-10860 of 15,574 trials

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

NCT01343485

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

GARDASIL Vaccination

Planned Parenthood Federation of America365 participantsStarted Sep 2011

Glendale, Arizona, United States • Arvada, Colorado, United States • Denver, Colorado, United States +6 more locations

COMPLETEDPhase 22.2 miles

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

NCT01985126

The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at least 3 prior lines of therapy (including a proteasome inhibitor \[PI\] and immunomodulatory drug \[IMiD\]) or are double refractory to a PI and an IMiD.

Multiple Myeloma

Janssen Research & Development, LLC124 participantsStarted Sep 2013

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +20 more locations

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Find Trials by Condition in Chicago

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens